Mindpeak Announces CE-IVD Mark for Artificial Intelligence Breast Cancer Cell Quantification
admin@pathologynews.com2021-05-21T14:00:14+00:00Mindpeak, a European leader in computational pathology, announced today that it has received CE-IVD Mark for BreastIHC, an Artificial Intelligence software that detects and quantifies breast cancer cells, for primary diagnosis.











